TNF-α suppresses dendritic cell death and the production of reactive oxygen intermediates induced by plasma withdrawal

Experimental Dermatology

Volumn 13, Issue 5, 2004, Pages 282-288

  Um, Hong Duck ^a   Cho, Young Hun ^b   Kim, Do Kyun ^c   Shin, Jong Ran ^b   Lee, Yung Jae ^b   Choi, Kwang Sung ^d   Kang, Jin Moon ^b   Lee, Min Geol ^b,e  

^a Korea Inst of Radiologial/Med Sci   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Inha University School of Medicine   (South Korea)

^e Yonsei University   (South Korea)

Author keywords

Antioxidants; Catalase; Dendritic cells; N acetylcysteine; Reactive oxygen intermediates; Tumor necrosis factor alpha

Indexed keywords

ACETYLCYSTEINE; CATALASE; CYTOKINE; GLUTATHIONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; SCAVENGER; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INCUBATION TIME; LIFESPAN; MONOCYTE; PLASMA; PROTEIN FUNCTION;

ACETYLCYSTEINE; ANTIGENS, CD; ANTIOXIDANTS; CATALASE; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CULTURE MEDIA; CYTOKINES; DENDRITIC CELLS; DINOPROSTONE; FLOW CYTOMETRY; GLUTATHIONE; HLA-DR ANTIGENS; HUMANS; HYDROGEN PEROXIDE; PLASMA; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2642526842     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2004.00146.x     Document Type: Article

References (42)

1. Cumberbatch M, Dearman R J, Griffiths C E, Kimber I. Langerhans cell migration. Clin Exp Dermatol 2000: 25: 413-418.
2. Austyn J M. Dendritic cells. Curr Opin Hematol 1998: 5: 3-15.
3. Cerio R, Griffiths C E, Cooper K D, Nickoloff B J, Headington J T. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol 1989: 121: 421-431.
4. Nestle F O, Zheng X G, Thompson C B, Turka L A, Nickoloff B J. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol 1993: 151: 6535-6545.
5. McLellan A D, Heiser A, Sorg R V, Fearnley D B, Hart D N. Dermal dendritic cells associated with T lymphocytes in normal human skin display an activated phenotype. J Invest Dermatol 1998: 111: 841-849.
6. Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000: 18: 767-811.
7. Banchereau J, Steinman R M. Dendritic cells and the control of immunity. Nature 1998: 392: 245-252.
8. Reinhard G, Märten A, Kiske S M, Feil F, Bieber T, Schmidt-Wolf I G H. Generation of dendritic cell-based vaccines for cancer therapy. Br J Cancer 2002: 86: 1529-1533.
9. Stockwin L H, McGonagle D, Martin I G, Blair G E. Dendritic cells: immunological sentinels with a central role in health and disease. Immunol Cell Biol 2000: 78: 91-102.
10. Lambrecht B N. Allergen uptake and presentation by dendritic cells. Curr Opin Allergy Clin Immunol 2001: 1: 51-59.
11. Reid C D, Stackpoole A, Meager A, Tikerpae J. Interactions of tumor necrosis factor with granulocyte-macrophage colony stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J Immunol 1992: 149: 2681-2688.
12. Egner W, Hart D N. The phenotypes of freshly isolated and cultured human bone marrow allostimulatory cells: possible heterogeneity in bone marrow dendritic cell populations. Immunology 1995: 85:611-620.
13. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 1992: 360: 258-261.
14. Rosenzwajg M, Canque B, Gluckman J C. Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells. Blood 1996: 87: 535-544.
15. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994: 179: 1109-1118.
16. Romani N, Gruner S, Brang D et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994: 180: 83-93.
17. Choi G S, Kang J M, Lee M G. Analysis of methods for the generation of dendritic cells from human peripheral blood monocytes. Yonsei Med J 2000: 41: 642-650.
18. Grassi F, Dezutter-Dambuyant C, McIlroy D et al. Monocyte-derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules. J Leukoc Biol 1998: 64: 484-493.
19. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996: 184: 1397-1411.
20. + and slow release of reactive oxygen species are two cross-talked events important in tumor necrosis factor-alpha mediated apoptosis. Free Radic Res 2000: 33: 295-304.
21. Bohler T, Waiser J, Hepburn H et al. TNF-α and IL-1 alpha induce apoptosis in subconfluent rat mesangial cells. Evidence for the involvement of hydrogen peroxide and lipid peroxidation as second messengers. Cytokine 2000: 12: 986-991.
22. Sidoti-de Fraisse C, Rincheval V, Risler Y, Mignotte B, Vayssiere J L. TNF-α activates at least two apoptotic signaling cascades. Oncogene 1998: 17: 1639-1651.
23. Vercammen D, Beyaert R, Denecker G et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 1998: 187: 1477-1485.
24. Goossens V, Grooten J, Fiers W. The oxidative metabolism of glutamine A modulator of reactive oxygen intermediate-mediated cytotoxicity of tumor necrosis factor in L929 fibrosarcoma cells. J Biol Chem 1996: 271: 192-196.
25. 2 and tumor necrosis factor-alpha in endothelial and epithelial cells. J Biol Chem 1997: 272: 32910-32918.
26. Ludewig B, Graf D, Gelderblom H R, Becker Y, Kroczek R, Pauli G. Spontaneous apoptosis of dendritic cell is efficiently inhibited by TRAP (CD40-ligand) and TNF-α, but strongly enhanced by interleukin-10. Eur J Immunol 1995: 25: 1943-1950.
27. Koppi T A, Tough-Bement T, Lewinsohn D H, Lynch D H, Alderson M R. CD40 ligand inhibits Fas/CD95-mediated apoptosis of human blood derived dendritic cells. Eur J Immunol 1997: 27: 3161-3165.
28. Haendeler J, Weiland U, Zeiher A M, Dimmeler S. Effects of redox-related congeners of NO on apoptosis and caspase-3 activity. Nitric Oxide 1997: 1: 282-293.
29. Satoh T, Sakai N, Enokido Y, Uchiyama Y, Hatanaka H. Survival factor-insensitive generation of reactive oxygen species induced by serum deprivation in neuronal cells. Brain Res 1996: 733: 9-14.
30. Jonuleit H, Kühn U, Müller G et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997: 27: 3135-3142.
31. Bass D A, Parce W, Dechatelet L R, Szejda P, Seeds MC, Thimas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 1983: 130: 1910-1917.
32. Mangan D, Welch G R, Wahl S M. Lipopolysaccharide, TNF-α, and IL-1β prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J Immunol 1991: 146: 1541-1546.
33. Goruppi S, Ruaro E, Schneider C. Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene 1996: 12: 471-480.
34. Wong G H, Kaspar R L, Vehar G. Tumor necrosis factor and lymphotoxin: protection against oxidative stress through induction of MnSOD. EXS 1996: 77: 321-333.
35. Yamashita K, Takahashi A, Kobayashi S et al. Caspases mediate tumor necrosis factor-alpha-induced neutrophil apoptosis and downregulation of reactive oxygen production. Blood 1999: 93: 674-685.
36. Schulze-Osthoff K, Bauer M K, Vogt M, Wesselborg S. Oxidative stress and signal transduction. Int J Vitam Nutr Res 1997: 67: 336-342.
37. Satriano J A, Shuldiner M, Hora K, Xing Y, Shan Z, Schlondorff D. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest 1993: 9: 1564-1571.
38. Gius D, Botero A, Shah S, Curry H A. Intracellular oxidation/reduction status in the regulation of transcription factors NF-kappaB and AP-1. Toxicol Lett 1999: 106: 93-106.
39. Bogdan C, Rollinghoff M, Diefenbach A. Reactive oxygen and reactive nitrogen intermediate in innate and specific immunity. Curr Opin Immunol 2000: 12: 64-76.
40. Iwai I, Hatao M, Naganuma M, Kumano Y, Ichihashi M. UVA-induced immune suppression through an oxidative pathway. J Invest Dermatol 1999: 112: 19-24.
41. Rutault K, Alderman C, Chain B M, Katz D R. Reactive oxygen species activate human peripheral blood dendritic cells. Free Radic Biol Med 1999: 26: 232-238.
42. Verhasselt V, Goldman M, Willems F. Oxidative stress upregulates IL-8 and TNF-α synthesis by human dendritic cell. Eur J Immunol 1998: 28: 3886-3890.